| Year |
Citation |
Score |
| 2023 |
Jeng KS, Chang CF, Sheen IS, Jeng CJ, Wang CH. Cellular and Molecular Biology of Cancer Stem Cells of Hepatocellular Carcinoma. International Journal of Molecular Sciences. 24. PMID 36674932 DOI: 10.3390/ijms24021417 |
0.383 |
|
| 2018 |
Jeng KS, Jeng CJ, Sheen IS, Wu SH, Lu SJ, Wang CH, Chang CF. Glioma-Associated Oncogene Homolog Inhibitors Have the Potential of Suppressing Cancer Stem Cells of Breast Cancer. International Journal of Molecular Sciences. 19. PMID 29734730 DOI: 10.3390/ijms19051375 |
0.401 |
|
| 2017 |
Jeng KS, Jeng CJ, Jeng WJ, Sheen IS, Li SY, Lu SJ, Chang CF. Tropism of liver epithelial cells toward hepatocellular carcinoma in vitro and in vivo with altering gene expression of cancer stem cells. American Journal of Surgery. PMID 29246405 DOI: 10.1016/j.amjsurg.2017.11.041 |
0.332 |
|
| 2017 |
Chen Y, Liu YC, Sung YC, Ramjiawan RR, Lin TT, Chang CC, Jeng KS, Chang CF, Liu CH, Gao DY, Hsu FF, Duyverman AM, Kitahara S, Huang P, Dima S, et al. Overcoming sorafenib evasion in hepatocellular carcinoma using CXCR4-targeted nanoparticles to co-deliver MEK-inhibitors. Scientific Reports. 7: 44123. PMID 28276530 DOI: 10.1038/Srep44123 |
0.306 |
|
| 2015 |
Jeng KS, Jeng CJ, Jeng WJ, Sheen IS, Li SY, Hung ZH, Hsiau HI, Yu MC, Chang CF. Liver epithelial cells inhibit proliferation and invasiveness of hepatoma cells. Oncology Reports. PMID 26647726 DOI: 10.3892/or.2015.4478 |
0.334 |
|
| 2012 |
Chang CF, D'Souza WN, Ch'en IL, Pages G, Pouyssegur J, Hedrick SM. Polar opposites: Erk direction of CD4 T cell subsets. Journal of Immunology (Baltimore, Md. : 1950). 189: 721-31. PMID 22675204 DOI: 10.4049/Jimmunol.1103015 |
0.552 |
|
| 2008 |
D'Souza WN, Chang CF, Fischer AM, Li M, Hedrick SM. The Erk2 MAPK regulates CD8 T cell proliferation and survival. Journal of Immunology (Baltimore, Md. : 1950). 181: 7617-29. PMID 19017950 DOI: 10.4049/Jimmunol.181.11.7617 |
0.346 |
|
| Show low-probability matches. |